NEW YORK (Reuters) - The head of the U.S. Food & Drug Administration Scott Gottlieb said on Wednesday that he was concerned about the impact of deals like the CVS Health purchase of Aetna Inc on the ability of pharmaceutical companies to block the en...
Original Article: FDA's Gottlieb eyes PBM consolidation impact on generic entry: CNBC